We are live on
!
Find out more
EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
60 hedge funds and large institutions have $530M invested in ESSA Pharma in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,800% more call options, than puts
Call options by funds: $171K | Put options by funds: $9K
79% more capital invested
Capital invested by funds: $297M → $530M (+$234M)
32% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 19
0.37% more ownership
Funds ownership: 84.52% → 84.89% (+0.37%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
20% less funds holding
Funds holding: 75 → 60 (-15)
71% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 21
Holders
60
Holders Change
-15
Holders Change %
-20%
% of All Funds
0.92%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
25
Reduced
19
Closed
21
Calls
$171K
Puts
$9K
Net Calls
+$162K
Net Calls Change
+$162K
Top Buyers
Top Sellers
| 1 |
Two Sigma Investments
New York
|
-$5.4M |
| 2 |
Two Sigma Advisers
New York
|
-$4.55M |
| 3 |
VC
Vivo Capital
Palo Alto,
California
|
-$3.48M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.25M |
| 5 |
D.E. Shaw & Co
New York
|
-$2.02M |
